HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hypercapnia

A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
Networked: 3473 relevant articles (111 outcomes, 302 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Anoxia (Hypoxia)
2. Respiratory Insufficiency (Respiratory Failure)
3. Acidosis
4. Chronic Obstructive Pulmonary Disease (COPD)
5. Respiratory Acidosis

Experts

1. Sznajder, Jacob I: 15 articles (12/2015 - 02/2002)
2. Ainslie, Philip N: 14 articles (11/2015 - 07/2004)
3. Nurse, Colin A: 12 articles (08/2014 - 12/2004)
4. Kavanagh, Brian P: 11 articles (02/2015 - 11/2003)
5. Taylor, Barbara E: 11 articles (11/2014 - 03/2003)
6. Putnam, Robert W: 10 articles (12/2014 - 01/2003)
7. Perry, Steve F: 9 articles (02/2015 - 04/2005)
8. Fisher, Joseph A: 9 articles (08/2014 - 05/2005)
9. Jankov, Robert P: 9 articles (04/2014 - 12/2003)
10. Bari, Ferenc: 9 articles (01/2013 - 04/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hypercapnia:
1. OxygenIBA
2. Carbon MonoxideIBA
3. Carbon DioxideIBA
4. GasesIBA
5. Lactic AcidFDA LinkGeneric
6. MuscimolIBA
7. Nitric Oxide (Nitrogen Monoxide)FDA Link
8. Acetazolamide (Diamox)FDA LinkGeneric
9. AdenosineFDA LinkGeneric
10. Propofol (Diprivan)FDA LinkGeneric

Therapies and Procedures

1. Positive-Pressure Respiration (PEEP)
2. Mechanical Ventilators (Ventilator)
3. Artificial Respiration (Mechanical Ventilation)
4. Anesthesia
5. Extracorporeal Membrane Oxygenation (ECMO)
04/01/1997 - "Extracorporeal CO2 removal using a low-resistance gas exchanger in a simple arteriovenous shunt allows significant reduction in minute ventilation and peak inspiratory pressure without hypercapnia or the complex circuitry and monitoring required for conventional extracorporeal membrane oxygenation. "
03/01/1997 - "From the individual and combined analyses the authors concluded: (1) CMV with ECMO as rescue produced an overall survival in CDH patients equivalent to CMV with HFOV in a parallel series, (2) neither HFOV nor ECMO has significantly improved outcome in CDH patients, (3) institution of permissive hypercapnia has resulted in a significant increase in survival, and (4) the leading causes of death in CDH patients appear to be associated anomalies and pulmonary hypoplasia, which are currently untreatable. "
03/01/1993 - "In our current study, we have applied ITPV in two neonates with CDH who could not be weaned from ECMO because of uncontrollable hypercapnia, and who met above criteria for 100% mortality. "
04/01/2012 - "The use of permissive hypercapnia for infants with CDH was associated with decreased mortality, a longer period of ventilation before repair with a shorter period of ventilation after repair, a lower rate of ECMO use, and no lengthening of hospital stay. "
04/01/2012 - "This retrospective review compares outcomes of infants treated for CDH in the extracorporeal membrane oxygenation (ECMO) era before and after initiation of permissive hypercapnia at a single institution. "